Greif, Inc. Declares Quarterly Dividend
DELAWARE, Ohio, Feb. 26, 2024 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products […]
Cricut to Present at Upcoming Investor Conferences
SOUTH JORDAN, Utah, Feb. 26, 2024 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has […]
Agora, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in […]
Premier Health Reports 2024 First Quarter Results
MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech […]
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating […]
Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2023 Results
– Acquired 75 USPS Properties for $20.7 Million in Fourth Quarter 2023 –– Net Income Attributable to Common Shareholders of $0.12 […]
iPower to Participate in the Water Tower Research Fireside Chat Series on February 28
DUARTE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven […]
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on […]
Eightco announces early repayment of debt, private placement and certain changes at the parent company level
Easton, PA, Feb. 26, 2024 (GLOBE NEWSWIRE) — Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company”) today announced that it has, […]
Travere Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate […]
